DENTSPLY SIRONA (NASDAQ:XRAY - Get Free Report) is expected to be issuing its quarterly earnings data before the market opens on Thursday, February 27th. Analysts expect the company to announce earnings of $0.47 per share and revenue of $920.26 million for the quarter. Parties that wish to listen to the company's conference call can do so using this link.
DENTSPLY SIRONA Price Performance
Shares of XRAY traded down $0.20 during trading hours on Friday, hitting $18.75. 1,765,748 shares of the stock were exchanged, compared to its average volume of 2,093,885. The stock's 50-day moving average price is $18.92 and its two-hundred day moving average price is $21.71. DENTSPLY SIRONA has a 12-month low of $17.21 and a 12-month high of $34.91. The company has a debt-to-equity ratio of 0.72, a quick ratio of 0.84 and a current ratio of 1.25. The company has a market cap of $3.73 billion, a price-to-earnings ratio of -9.06, a price-to-earnings-growth ratio of 1.80 and a beta of 0.96.
DENTSPLY SIRONA Announces Dividend
The firm also recently announced a quarterly dividend, which was paid on Friday, January 10th. Stockholders of record on Friday, December 27th were issued a dividend of $0.16 per share. This represents a $0.64 dividend on an annualized basis and a dividend yield of 3.41%. The ex-dividend date was Friday, December 27th. DENTSPLY SIRONA's payout ratio is -30.92%.
Wall Street Analyst Weigh In
XRAY has been the topic of a number of recent research reports. Leerink Partnrs lowered shares of DENTSPLY SIRONA from a "strong-buy" rating to a "hold" rating in a research report on Thursday, November 7th. Barrington Research dropped their price target on DENTSPLY SIRONA from $36.00 to $24.00 and set an "outperform" rating for the company in a research report on Friday, November 8th. StockNews.com raised DENTSPLY SIRONA from a "hold" rating to a "buy" rating in a research note on Tuesday. Leerink Partners cut DENTSPLY SIRONA from an "outperform" rating to a "market perform" rating in a report on Thursday, November 7th. Finally, Mizuho started coverage on DENTSPLY SIRONA in a report on Wednesday, December 4th. They set a "neutral" rating and a $21.00 price target on the stock. Ten research analysts have rated the stock with a hold rating and five have given a buy rating to the company. According to data from MarketBeat.com, DENTSPLY SIRONA presently has an average rating of "Hold" and a consensus target price of $25.85.
Check Out Our Latest Analysis on XRAY
About DENTSPLY SIRONA
(
Get Free Report)
DENTSPLY SIRONA Inc manufactures and sells various dental products and technologies worldwide. It operates in four segments: Connected Technology Solutions, Essential Dental Solutions, Orthodontic and Implant Solutions, and Wellspect Healthcare. The company offers dental equipment comprising imaging equipment, motorized dental handpieces, treatment centers, other instruments, amalgamators, mixing machines, and porcelain furnaces; and dental CAD/CAM technologies to support dental restorations, such as intraoral scanners, 3-D printers, mills, other software and services, and a full-chairside economical restoration of esthetic ceramic dentistry, as well as DS Core, its cloud-based platform.
Featured Stories
Before you consider DENTSPLY SIRONA, you'll want to hear this.
MarketBeat keeps track of Wall Street's top-rated and best performing research analysts and the stocks they recommend to their clients on a daily basis. MarketBeat has identified the five stocks that top analysts are quietly whispering to their clients to buy now before the broader market catches on... and DENTSPLY SIRONA wasn't on the list.
While DENTSPLY SIRONA currently has a "Hold" rating among analysts, top-rated analysts believe these five stocks are better buys.
View The Five Stocks Here
If a company's CEO, COO, and CFO were all selling shares of their stock, would you want to know? MarketBeat just compiled its list of the twelve stocks that corporate insiders are abandoning. Complete the form below to see which companies made the list.
Get This Free Report
Like this article? Share it with a colleague.
Link copied to clipboard.
